-
Guggenheim Reaffirms Buy Rating for Dyne Therapeutics (NASDAQ:DYN)
Source: Buzz FX / 25 Jan 2025 10:35:18 America/Chicago
Guggenheim Reaffirms Buy Rating for Dyne Therapeutics (NASDAQ:DYN) Written by MarketBeat January 25, 2025 Share Link copied to clipboard. Dyne Therapeutics ( NASDAQ:DYN - Get Free Report ) 's stock had its "buy" rating restated by equities
Read more...